Shri Amit Agrawal, Secretary, Department of Pharmaceuticals (DoP), Ministry of Chemicals & Fertilizers, Government of India (GoI), emphasized the rapid progress of India’s medical devices sector and reaffirmed the government’s commitment to making the industry self-reliant.
“Over the last five years, India has taken major strides towards self-sufficiency in medical device production. The domestic share has risen from under 10% to 30%, and even for advanced high-end devices, our share now stands at 20%,” Shri Agrawal stated.
Calling the second edition of India MedTech Expo 2025 a resounding success, he recalled, “When we organized the first edition nearly two years ago, global participants were keen on Class A and B non-invasive products. This year, thousands of foreign delegates from 30 countries have shown strong interest in Class C advanced invasive products. India is producing these at 10–40% lower cost, presenting immense export potential.”
During his visit to the expo, Shri Agrawal interacted with industry leaders and reiterated DoP’s resolve to collaborate with stakeholders to make India Atmanirbhar in medical devices and MedTech.
In the final session titled “Meeting with Global Regulators: Shaping a Future-ready MedTech Regulatory Ecosystem,” senior officials emphasized areas for improvement.
Ms. Sai Ahlladini Panda, Member Secretary, NPPA, highlighted the urgent need for robust clinical and non-clinical data to improve device quality, noting India’s rising life expectancy as a driver of demand.
Ms. Gayatri Nair, Economic Advisor, DoP, assured that the department is supporting capacity-building initiatives with both short-term and long-term training programs to strengthen the workforce.
Shri Aseem Sahu, Deputy Drug Controller, CDSCO, pointed out that the regulatory environment has matured, with medical device manufacturers increasing from around 400 to over 4,000 in just five years.
Prof. Salah Derradji from Algeria encouraged Indian manufacturers to explore opportunities in his country, which currently produces only 2% of its device requirements.
Shri Hitendra Sahu, Director, DoP, stressed the need to raise testing standards, stating: “With India meeting just 2% of global demand, improving quality to global benchmarks can multiply exports manyfold.”
Organized by the DoP in association with the Ministry of Commerce & Industry, EPCMD, and CDSCO, the India MedTech Expo 2025 was held from September 4–6, 2025 at Bharat Mandapam, Pragati Maidan, New Delhi.
This year’s theme, “India: Global MedTech Manufacturing Hub – Precision Engineering yet Affordable” showcased India’s achievements through exhibitions, state-led pavilions, innovation zones, CEO roundtables, regulator open houses, and B2B sessions.
The event brought together over 500 domestic participants, 150 global buyers from 30+ countries, start-ups, MSMEs, state governments, and industry leaders, further strengthening India’s position as a global MedTech hub. Supported by major associations such as AIMED, CII, FICCI, USIBC, USISPF, and others, the expo cemented India’s growing role in advancing affordable, high-quality healthcare solutions worldwide.
